
Home » WITH MS DRUG STATUS IN LIMBO, FIRMS WORK ON PATIENT CONFIDENCE
WITH MS DRUG STATUS IN LIMBO, FIRMS WORK ON PATIENT CONFIDENCE
It was barely two hours after a panel recommended to the Food and Drug Administration that it allow the drug Tysabri back on the market when Dr. Joseph Berger got an e-mail inviting him to a special class.
The
Star-Telegram
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct